Kyongbo Pharmaceutical Co., Ltd

KRX:214390.KS

5010 (KRW) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q2
Revenue 60,58859,313.63158,23058,411.47562,600.41961,267.54354,581.94552,554.19447,953.79957,812.36949,330.65446,107.15343,014.72741,943.06638,959.24946,064.70343,692.62748,542.63954,737.22860,199.45651,805.77248,605.54645,295.88352,889.47844,915.28353,070.4450,290.47950,721.54347,261.13448,531.44146,633.22451,129.67245,367.03743,850.13646,876.15151,122.71244,877.17245,728.24645,296.61843,658.96843,348.845,530.22741,129.5341,573.44
Cost of Revenue 60,58835,829.91238,121.0640,029.90742,892.54544,287.57838,572.01236,746.09135,256.74242,674.13139,475.15536,136.11733,561.62734,632.6532,169.46935,546.94932,950.28636,937.10241,535.37245,308.74639,039.13540,235.37136,356.19239,326.97135,071.50240,773.60538,714.05537,906.06434,688.69336,246.9431,425.4937,239.75432,126.49932,652.45837,707.20939,340.45332,922.64733,696.38333,327.61731,026.75531,424.63234,871.45129,147.08128,811.073
Gross Profit 023,483.71920,108.9418,381.56819,707.87516,979.96516,009.93315,808.10312,697.05715,138.2389,855.4999,971.0359,453.17,310.4166,789.7810,517.75510,742.34111,605.53713,201.85614,890.7112,766.6378,370.1758,939.69113,562.5069,843.78112,296.83411,576.42412,815.47912,572.44112,284.50115,207.73413,889.91813,240.53811,197.6789,168.94211,782.25911,954.52512,031.86311,969.00112,632.21311,924.16810,658.77611,982.44912,762.367
Gross Profit Ratio 00.3960.3450.3150.3150.2770.2930.3010.2650.2620.20.2160.220.1740.1740.2280.2460.2390.2410.2470.2460.1720.1970.2560.2190.2320.230.2530.2660.2530.3260.2720.2920.2550.1960.230.2660.2630.2640.2890.2750.2340.2910.307
Reseach & Development Expenses 000003,596.0752,739.6723,244.2662,805.5491,964.2412,746.6522,304.7630000000000000102.846270.734122.809273.38887.118109.859309.939258.487574.884211.831325.338372.405427.403534.078390.338514.919502.461421.235209.056
General & Administrative Expenses 0-49,093.26816,951.54717,113.90617,389.073-39,415.23514,270.79114,318.65813,207.181-29,733.63510,738.54410,759.70110,149.002-29,071.49810,472.03910,757.19310,130.543-28,824.39611,092.30610,032.29110,630.322-20,481.7677,989.3538,409.6968,062.05915.177888.105842.632643.976620.79970.1991,371.1151,410.014852.9231,242.9361,116.2741,035.751958.524953.138892.026751.265946.451,002.495-865.2
Selling & Marketing Expenses 044,680.59200-4,477.99453,568.89200000000000000000001,934.2342,164.412,009.9481,898.1882,339.3531,980.2781,848.0121,728.341,302.9541,384.1151,727.6482,010.3811,213.9331,330.6561,125.7791,500.771,454.8071,477.3891,819.106
SG&A 0-4,412.67616,951.54717,113.90617,389.07314,153.65714,270.79114,318.65813,207.181-7,610.77410,738.54410,759.70110,149.002-11,917.94410,472.03910,757.19310,130.543-17,420.43811,092.30610,032.29110,630.322-11,607.0047,989.3538,409.6968,062.052,849.4113,052.5152,852.582,542.1642,960.1432,950.4773,219.1273,138.3542,155.8772,627.0512,843.9223,046.1322,172.4572,283.7942,017.8052,252.0352,401.2572,479.884953.906
Other Expenses 60,46724,924.771000249.863-28,541.58284.94-26,414.36218,988.74894.206-225.9951,368.438246.309158.904129.034153.138-2,430.77968.0991,648.61297.638-1,715.451666.089-166.4241,473.335105.4822.1137.19131.8451,838.42777.924161.689113.615191.654143.39240.073230.457228.24639.892310.43870.403382.635-140.3853,112.37
Operating Expenses 60,46720,512.09516,951.54717,113.90617,389.07314,153.657-14,270.79114,318.658-13,207.18111,377.97410,738.54410,759.70110,149.00210,625.36210,472.03910,757.19310,130.54312,048.38811,092.30610,032.29110,630.32210,060.9817,989.3538,409.6968,062.058,605.4268,038.0257,973.4397,377.7136,771.6867,751.5237,878.7667,634.0677,705.046,768.4897,504.7586,530.8876,209.3485,870.5735,628.345,216.656,758.2746,843.0034,117.238
Operating Income 1212,971.6253,1581,267.6623,056.4472,826.3091,739.1421,489.445-510.1243,760.264-883.045-788.665-695.902-3,314.946-3,682.259-239.438611.799-442.8512,109.554,858.4192,136.315-1,690.807950.3385,152.8111,781.7313,691.4093,538.3994,842.0395,194.7285,512.8157,456.2126,011.1515,606.4713,492.6382,400.4524,277.5015,423.6365,822.5156,098.4287,003.8746,707.5183,900.5035,139.4478,645.129
Operating Income Ratio 0.0020.050.0540.0220.0490.0460.0320.028-0.0110.065-0.018-0.017-0.016-0.079-0.095-0.0050.014-0.0090.0390.0810.041-0.0350.0210.0970.040.070.070.0950.110.1140.160.1180.1240.080.0510.0840.1210.1270.1350.160.1550.0860.1250.208
Total Other Income Expenses Net -1,103-1,667.545-1,764-1,024.011-1,095.992-1,100.229-913.869-933.832-424.918-2,071.52153.511-567.529478.05-904.308-2,181.894-1,566.7541,344.853-1,658.5381,836.671,366.402854.649-561.375627.622-509.6661,231.499-1,314.067-380.501-33.173140.056326.3086.917-68.005-967.418788.267-956.754-56.37-468.985-411.124571.104-193.058-358.609319.321-226.1342,523.399
Income Before Tax -9821,304.081,394243.6511,960.4551,999.923825.273555.613-935.0411,688.745-729.534-1,356.195-217.852-4,219.254-5,864.153-1,806.1921,956.651868.7883,946.226,224.822,990.964-2,252.1811,577.9614,643.1443,013.233,955.2643,157.8985,195.6035,334.7835,839.1257,463.1276,319.7344,639.0534,280.9051,443.6984,616.6445,301.8385,411.3916,669.5327,102.4776,348.9084,219.8244,913.31311,168.527
Income Before Tax Ratio -0.0160.0220.0240.0040.0310.0330.0150.011-0.0190.029-0.015-0.029-0.005-0.101-0.151-0.0390.0450.0180.0720.1030.058-0.0460.0350.0880.0670.0750.0630.1020.1130.120.160.1240.1020.0980.0310.090.1180.1180.1470.1630.1460.0930.1190.269
Income Tax Expense -287-447.62131387.135310.714-311.13860.779-356.95-195.166265.411-774.859-338.493-377.485-1,132.587-1,321.848-421.807438.474532.0961,479.8671,629.276985.107-434.639130.2661,145.116856.172978.972869.4211,386.8291,292.2761,535.8471,877.8451,757.1531,126.884858.531236.729940.978900.917-4,916.4331,577.8881,405.3341,355.89715,768.877738.9482,552.704
Net Income -6951,751.71,081156.5161,649.7412,037.218764.494912.563-739.8751,423.33345.325-1,017.701159.633-3,086.667-4,542.305-1,384.3851,518.178336.6922,466.3534,595.5442,005.857-1,817.5421,447.6953,498.0282,157.0582,976.292,288.4783,808.7744,042.5074,303.2785,585.2824,562.5813,512.1693,422.3741,206.9693,675.6654,400.92110,327.8245,091.6455,697.1424,993.012-11,549.0534,174.3658,615.823
Net Income Ratio -0.0110.030.0190.0030.0260.0330.0140.017-0.0150.0250.001-0.0220.004-0.074-0.117-0.030.0350.0070.0450.0760.039-0.0370.0320.0660.0480.0560.0460.0750.0860.0890.120.0890.0770.0780.0260.0720.0980.2260.1120.130.115-0.2540.1010.207
EPS -29.0773.2745.226.5569.0185.2131.9838.17-30.9559.541.9-437-130.78-190-5864-910319284-7661146901259615916918023419114714350154184442213263232-535.01194400
EPS Diluted -29.0773.2745.226.5569.0185.2131.9838.17-30.9559.541.9-437-130.78-190-5864-910319284-7661146901259615916918023419114714350154184442213263232-535.01194400
EBITDA 1214,805.3086,253.17918,381.5686,671.7815,816.70916,009.9334,433.9712,348.6996,600.0431,940.4412,304.0832,483.821226.114-483.2783,063.7783,681.712,577.7488,039.6514,858.4192,136.315395.4094,055.6655,152.8116,258.8756,650.0966,404.7917,690.1148,059.6718,957.6410,328.8088,853.8538,456.1726,357.765,194.4136,750.927,730.8818,195.3568,995.8768,893.7498,513.5535,937.9257,111.14111,656.029
EBITDA Ratio 0.0020.0810.1070.3150.1070.0950.2930.0840.0490.1140.0390.050.0580.005-0.0120.0670.0840.0530.1470.0810.0410.0080.090.0970.1390.1250.1270.1520.1710.1850.2210.1730.1860.1450.1110.1320.1720.1790.1990.2040.1960.130.1730.28